Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
291.60
-0.49 (-0.17%)
Oct 29, 2025, 11:25 AM EDT - Market open
Amgen Revenue
Amgen had revenue of $9.18B in the quarter ending June 30, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.92B, up 12.88% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.92B
Revenue Growth
+12.88%
P/S Ratio
4.50
Revenue / Employee
$1,247,036
Employees
28,000
Market Cap
156.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AMGN News
- 6 days ago - These low-risk stocks could be a profitable answer to this volatile earnings season - Market Watch
- 6 days ago - Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 11 days ago - US FDA expands use of Amgen, AstraZeneca's drug for sinus infection - Reuters
- 11 days ago - FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS - PRNewsWire
- 21 days ago - Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers - CNBC
- 22 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 23 days ago - Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts - WSJ
- 23 days ago - Amgen to sell cholesterol drug at 60% discount direct to US consumers - Reuters